Funding news
Pacific Edge Ltd logo

Pacific Edge Ltd Raises $14.3M to

Recently funded · $14.3M UnknownHospitals and Health CareNZView source

Get the full Pacific Edge Ltd company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Pacific Edge Ltd, the New Zealand-based cancer diagnostics firm behind the Cxbladder suite of tests, has secured $14.3M in new capital. The funding will bolster the company's global efforts in developing and commercializing its non-invasive genomic urine tests for bladder cancer.

Headquartered in Dunedin, Pacific Edge's Cxbladder tests are designed to improve patient experience and optimize clinical workflows by stratifying the risk of urothelial cancer. The tests, supported by over 20 years of research, are already available in the US, Australasia, Israel, and parts of Asia and South America, with Cxbladder Triage included in the American Urological Association’s Microhematuria Guideline.

Other New Zealand companies recently funded

View all

Biggest recent Healthcare rounds

Largest funding rounds in Healthcare on Signalbase right now.

#CompanyAmount
1
Kismet logo

Kismet

Australia

$42.0B
2
Johnson & Johnson logo

Johnson & Johnson

United States

$7.0B
3
Inari Medical logo

Inari Medical

United States

$4.9B
4
MultiPlan logo

MultiPlan

United States

$4.5B
5
Edwards Lifesciences logo

Edwards Lifesciences

United States

$4.2B

Other recent Unknown rounds

Companies that recently closed a Unknown round.

#CompanyAmount
1
Arib logo

Arib

Saudi Arabia

$23.5M
2
LaNova Medicines logo

LaNova Medicines

$200.0M
3
Jiusheng(TEC)electric co., ltd. logo

Jiusheng(TEC)electric co., ltd.

China

$427.0M
4
XbotGo logo

XbotGo

United States

$13.8M
5
Choco Up logo

Choco Up

Singapore

$30.0M